Skip to content

Vitamin D Level and Its Relation to Pre-eclampsia and Eclampsia

Vitamin D Level in Patients With Pre-eclampsia, Eclampsia and Normal Full Term Pregnant

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03882099
Enrollment
500
Registered
2019-03-20
Start date
2019-03-17
Completion date
2019-10-31
Last updated
2019-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eclampsia, Antepartum, Pre-Eclampsia, Vitamin D Deficiency

Brief summary

To compare 25(OH)D level in patients with pre-eclampsia, eclampsia and normotensive pregnant women as well as to study the prevalence of Vitamin D deficiency among the 3 groups.

Detailed description

200 patients with pre-eclampsia, 100 with eclampsia and 200 normotensive pregnant controls attending Delivery/emergency department in Kasr Al Ainy hospital will be included in the study (from March 2019 till September 2019). 25(OH) D level will be measured for the three groups. * Preeclampsia is defined as systolic BP \>140 and/or diastolic BP\>90 on two occasions, 4 hours apart in pregnant females\>20 weeks, plus proteinuria \>/= 1+ urine dipstick protein. * Eclampsia defined as tonic-clonic seizures in women with pre-eclampsia. * Controls are normotensive pregnant females with no proteinuria and no other medical disorders. * The determination of 25(OH) D is based on a competitive enzyme-linked immunosorbant assay (ELISA) using the 25(OH)D3/D2 ELISA system (ORGENTIC DIAGNOSTIKA GmbH, Germany) Inclusion criteria: Age 20-35 years Gestational age 30-40 weeks Exclsion criteria: Twin pregnancy Other medical conditions during prrgnancy Drugs that influence Vit D levels eg.antiepileptics and antituberculous treatment.

Interventions

DIAGNOSTIC_TESTDetermination of Vitamin D by ELISA

Blood samples

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years

Inclusion criteria

* Age 20-35 years * Gestational age 30-40 weeks

Exclusion criteria

* Twin pregnancy * Other medical conditions during pregnancy * Drugs that influence Vit D levels eg.antiepileptics and antituberculous treatment

Design outcomes

Primary

MeasureTime frame
To compare vitamin D levels in the three groups6 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026